Its scientific findings on remdesivir’s effect on coronaviruses have been published in the Science Translational Medicine journal in June 2017 on how the drug, with the development code GS-5734, inhibits both epidemic and zoonotic coronaviruses. About Gilead Sciences. Mr. Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since 1993. When Thailand decided in 2006 and 2007 to break patents on drugs to treat HIV and heart disease, foreign drugs makers including Abbott Laboratories responded by withdrawing their products for treating other diseases from the Southeast Asian country. The Gilead Sciences Inc. headquarters in Foster City, Calif., on March 19, 2020. Our information suggests that Gilead Sciences, Inc. insiders own under 1% of the company. Please. Conversely, insiders often decrease their ownership over time. Drugs Associated with Gilead Sciences, Inc. Gilead Sciences, Inc. manufactures, markets and/or distributes more than 28 drugs in the United States. FMR LLC lifted its holdings in Gilead Sciences by 14.4% in the second quarter. Non-US country and region specific information is … If approved, the drug will be used to facilitate its potential global market entry, it added.Studies have been conducted outside the human bodies and found that Gilead’s remdesivir compound and the off-patent chloroquine malaria drug are both “highly effective” in the control of coronavirus infection, the Wuhan institute and the Beijing Institute of Pharmacology and Toxicology said in a research published in Cell Research Journal. Even if the Institute of Virology is granted the patent for the use of the drug on the novel coronavirus, it would not be able to get around any patents Gilead might have filed or obtained for the drug remdesivir, Cobden said. Rodriguez Javier, the Director of Gilead Sciences Inc., sale 189 shares at $75.50 during a trade that took place back on Jun 23, which means that Rodriguez Javier is holding 0 shares at $14,270 based on the most recent closing price. The company strives to transform and simplify care for people with life-threatening illnesses around the world. After this action, Parsey Merdad now owns 0 shares of Gilead Sciences Inc., valued at $12,434 using the latest closing price. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Get the hottest stocks to trade every day before the market opens 100% free. Gilead Sciences (NASDAQ: GILD) is owned by 76.73% institutional shareholders, 1.01% Gilead Sciences insiders, and 22.26% retail investors. Gilead Sciences Inc., down 52 cents to $60.11. It has also forced companies to shut their businesses in the mainland, forced border controls and rattled global markets. It is a very large company, so it would be surprising to see insiders own a large proportion of the company. Shares of American biotech firm Gilead Sciences rose nearly 5% Monday after an official from the World Health Organization said that Gilead's drug remdesivir is … BlackRock Inc. lifted its position in shares of Gilead Sciences by 14.4% in the second quarter. Blackrock Inc's Gilead Sciences shares are currently valued at $6.96B. The maker of Alpha-Bits and Grape-Nuts cereal disappointed investors with its fourth-quarter financial report. Management ultimately answers to the board. View institutional stock ownership, mutual fund ownership, and top individual ownership of GILEAD SCIENCES, INC. (GILD). Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. So they generally do consider buying larger companies that are included in the relevant benchmark index. Gilead Sciences priced its shares at $15 before its IPO. Gilead Sciences was founded in June 1987 by a medical doctor, Michael L. Riordan from Johns Hopkins School of Medicine and Harvard Business School. The viral outbreak has triggered panic across the globe, forcing the nation to lock down Wuhan and other cities in central Hubei province where the deadly virus originated. Gilead Sciences Inc. drug that they believe might fight the novel . The application in China is still pending. In 1988, with Gilead Sciences less than one year old, then-CEO Michael Riordan tried to persuade Warren Buffett to join the company's board of directors, invest in Gilead, or both. Gilead Sciences Inc. (NASDAQ:GILD) went down by -0.82% from its latest closing price compared to the recent 1-year high of $85.97. Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us which group is most powerful.Generally speaking, as a company grows, institutions will increase their ownership. China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on intellectual property and marketing rights.. BlackRock Inc. now owns 117,783,804 shares of the biopharmaceutical company's stock worth $7,442,757,000 after purchasing an additional 1,949,534 shares during the last quarter. FMR LLC lifted its holdings in Gilead Sciences by 14.4% in the second quarter. Conversely, insiders often decrease their ownership over time. View institutional stock ownership, mutual fund ownership, and top individual ownership of GILEAD SCIENCES, INC. (GILD). Find the latest Institutional Holdings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Capital Research and Management Company - Division 3, California State Teachers Retirement System, Robeco Institutional Asset Management B V, New York State Teachers Retirement System, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, Alberta Investment Management Corporation, State of New Jersey Common Pension Fund D, OTR - Nominee Name for The State Teachers Retirement Board of Ohio, Track 13F-HR Filings for Hedge Funds and Value Investors. To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol. Free copies of these materials and certain other offering documents will be made available by Gilead by mail to Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, attention: Investor Relations, by phone at 1-800-GILEAD-5 or 1-650-574-3000, or by directing requests for such materials to the information agent for the offer, which will be named in the Tender Offer Statement. “But a patent cannot stop doctors from prescribing the drug to treat a patient.”. Past clinical data on other coronaviruses give it “hope,” it added. FMR LLC lifted its holdings in Gilead Sciences by 14.4% in the 2nd quarter. Find the latest Institutional Holdings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. coronavirus. A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us which group is most powerful.Generally speaking, as a company grows, institutions will increase their ownership. Gilead Sciences, Inc. (US:GILD) has 2707 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Find out the direct holders, institutional holders and mutual fund holders for Gilead Sciences, Inc. (GILD). “Since these compounds have [separately] been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease,” the researchers wrote. Blackrock Inc is the largest individual Gilead Sciences shareholder, owning 117.78M shares representing 9.39% of the company. Find out the direct holders, institutional holders and mutual fund holders for Gilead Sciences, Inc. (GILD). A spokeswoman for the Foster City, California-based company said it had invented remdesivir, and had filed patent applications for the compound and its uses against coronaviruses globally, including in China, in 2016. Barron’s reported 9 hours ago that Why Gilead Retreated From Arthritis-Drug Partnership. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Our data suggests tha… Medical workers transfer a suspected coronavirus patient to an ambulance from the World Dream cruise ship at Kai Tak Cruise Terminal in Hong Kong on February 3. Past clinical data on other coronaviruses give it “hope,” it added.HK BUSINESS BRIEFINGGet updates direct to your inboxSUBSCRIBEBy registering, you agree to our TandC and Privacy Policy. Want to be notified whenever an investor makes a significant change to their holdings of Gilead Sciences? ETF holdings data are updated once a day, and are subject to change. “Another is whether they are inventive, that is, an ordinary researcher in this field would not have thought of combining those drugs, or using those drugs to treat the coronavirus.”, The Chinese researchers said the filing was based on “international practice” and for the “protection of national interest,” adding it will “temporarily not exercise any intellectual property rights if foreign pharmaceutical firms are willing to contribute towards combating the outbreak in China.”. Though their holding amount to less than 1%, we can see that board members collectively own US$169m worth of shares (at current prices). BlackRock Inc. discloses 8.40% ownership in GILD / Gilead Sciences, Inc. February 05, 2020 - BlackRock Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 106,473,594 shares of Gilead Sciences, Inc. (US:GILD). The following ETFs maintain exposure to Gilead Sciences, Inc. (GILD). Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. Post Holdings Inc., down $6.17 to $90.53. The World Health Organization recommended against using the biotechnology company's remdesivir for hospitalized COVID-19 patients. Gilead Sciences was founded in June 1987 by a medical doctor, Michael L. Riordan from Johns Hopkins School of Medicine and Harvard Business School. Past performance is a poor indicator of future performance. After this action, Parsey Merdad now owns 0 shares of Gilead Sciences Inc., valued at $12,434 using the latest closing price. China has applied to patent a drug candidate being developed by US biotechnology firm Gilead Sciences in its search for a cure for coronavirus infection. Photo: Sam Tsang. However, the biotech stock opened for trading at a little over $22 per share -- a gain of nearly 47% right off the bat for early investors. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. It is a very large company, so it would be surprising to see insiders own a large proportion of the company. This can indicate that the company has a certain degree of credibility in the investment community. It … BlackRock Inc. discloses 8.40% ownership in GILD / Gilead Sciences, Inc. February 05, 2020 - BlackRock Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 106,473,594 shares of Gilead Sciences, Inc. (US:GILD). The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The company’s stock price has collected -3.09% of loss in the last five trading sessions. 1 year ago. Indeed, they own 82% of the company. Medications listed here may also be marketed under different names in different countries. Blackrock Inc's Gilead Sciences shares are currently valued at $6.96B. China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on intellectual property and marketing rights. Drugs Associated with Gilead Sciences, Inc. Gilead Sciences, Inc. manufactures, markets and/or distributes more than 28 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Gilead Sciences was the second-best performing stock in the S&P 500 and was just one of two stocks in the Nasdaq-100 that was trading higher on … As you can see, institutional investors own 83% of Gilead Sciences. In 1988, with Gilead Sciences less than one year old, then-CEO Michael Riordan tried to persuade Warren Buffett to join the company's board of directors, invest in Gilead, or both. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Gilead Sciences Inc. GILD, -1.19% on Wednesday morning announced data from two clinical trials testing its experimental drug remdesivir in severely ill COVID-19 … Who bought or sold Gilead Sciences this quarter? Foster City, CA, January 3, 1997 – Gilead Sciences Inc. (Nasdaq: GILD) today announced that board member Donald H. Rumsfeld will assume the position of Chairman, effective immediately. Asked if Gilead will contest the patent application filed by the Chinese researchers, she said China’s “application has been filed more than three years after Gilead’s filing and will be considered in view of what is already known about the compound and pending patent applications. Gilead Sciences announced earlier in the day that the study had met its primary endpoint but did not provide further details. Foster City, CA, January 3, 1997 – Gilead Sciences Inc. (Nasdaq: GILD) today announced that board member Donald H. Rumsfeld will assume the position of Chairman, effective immediately. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. Though their holding amount to less than 1%, we can see that board members collectively own US$169m worth of shares (at current prices). BlackRock Inc. now owns 115,834,270 shares of the biopharmaceutical company’s stock worth $8,912,289,000 after buying an additional 14,619,279 shares in the last quarter. Find the latest news headlines from Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. BlackRock Inc. grew its stake in shares of Gilead Sciences by 1.7% in the third quarter. Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since 1993. President Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., makers of COVID-19 treatments. “One question is whether the specific combination of drugs or that specific medical use of the drug is novel, that is, the researchers who make a discovery have filed their patent application before it becomes known to the public,” Cobden said. Every investor in Gilead Sciences, Inc. (NASDAQ:GILD) should be aware of the most powerful shareholder groups.Generally speaking, as a company grows, institutions will increase their ownership. It might take 12 to 18 months for the public to know the coverage of the patent applied for by the Wuhan institute when its application document is published, and the entire patent granting process could take several years, if its case falls within the industry norm, Cobden said. They too, get it wrong sometimes. However, on some occasions too much power is concentrated within this group. Conversely, insiders often decrease their ownership over time. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Prior to Gilead, Daniel served as the Chief Executive Officer of Roche Pharmaceuticals. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. We note that hedge funds don’t have a meaningful investment in Gilead Sciences. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. So far, the virus has claimed more than 560 lives and infected at least 27,000 people, mostly in mainland China. These institutions hold a total of 1,713,061,316 shares. The head of the maker of remdesivir, an anti-viral shown to reduce recovery times in COVID-19 patients, said Sunday the company has been exporting the drug and is making it available to patients in the United States through the US government. China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on intellectual property and marketing rights.The state-backed Institute of Virology in Wuhan filed the patent for using remdesivir to fight the novel coronavirus on January 21, according to a statement posted on its website two weeks later on February 4. coronavirus. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Gilead Sciences, Inc.'s stock rating is based on fundamental analysis. Gilead Sciences already has institutions on the share registry. It is not know when the institute’s filing could be approved by China’s patent authority, but the unit of Chinese Academy of Sciences could provoke legal issues with its filing, according to Andrew Cobden, a patent and trademark lawyer in Hong Kong at Hogan Lovells in Hong Kong. Institutional investors commonly compare their own returns to the returns of a commonly followed index. Our information suggests that Gilead Sciences, Inc. insiders own under 1% of the company. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The move by the Wuhan institute, the most advanced virology centre in Asia, evoked similar past acts elsewhere in the region. China has applied to patent a drug candidate being developed by US biotechnology firm Gilead Sciences in its search for a cure for coronavirus infection. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. Gilead Sciences, Inc.'s stock rating is based on fundamental analysis. “Our focus at this time is on rapidly determining the potential for remdesivir as a treatment for [the novel coronavirus] and accelerating manufacturing in anticipation of potential future supply needs.”. Funds that own Gilead Sciences also own: Comcast Corporation (CMCSA) NVIDIA … © Pakistan Press International, source Asianet-Pakistan, Galapagos Shares Drop 19% After Gilead Won't Seek FDA Approval for Jyseleca. Gilead Sciences, Inc. (US:GILD) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Find the latest news headlines from Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. However, the biotech stock opened for trading at a little over $22 per share -- a gain of nearly 47% right off the bat for early investors. A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us … Remdesivir has not been approved anywhere globally and has not been showed to be safe or effective for any use, Gilead’s chief medical officer Merdad Parsey said in a statement on Friday.The firm is working with Chinese health authorities to conduct a clinical trial on patients with pneumonia symptoms to test its safety and efficacy, it said. To answer the first question, remdesivir is owned by Gilead Sciences, a US biotechnology company. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. China to open second coronavirus hospital built in 10 days, with more beds than first, Remdesivir has not been approved anywhere globally and has not been showed to be safe or effective for any use, Gilead’s chief medical officer Merdad Parsey said in a statement on Friday.The firm is working with Chinese health authorities to conduct a clinical trial on patients with pneumonia symptoms to test its safety and efficacy, it said. BlackRock Inc. grew its stake in shares of Gilead Sciences by 1.7% in the third quarter. President Xi Jinping said China must treat the fight against coronavirus as “the most important task at hand,” according to state broadcaster CCTV on February 3. Non-US country and region specific information is … BlackRock Inc. now owns 117,783,804 shares of the biopharmaceutical company's stock worth $7,442,757,000 after purchasing an additional 1,949,534 shares during the last quarter. Gilead Sciences Inc. drug that they believe might fight the novel . We are unable to comment on details of [their] application because there is an 18-month delay for an application to be published.”Gilead filed a patent in 2016 for methods to treat coronavirus infections, without mentioning remdesivir. “In theory, a patent owner may be able to use its patent to stop other companies from manufacturing, importing or selling that drug in China,” he said. Gilead Sciences (NASDAQ: GILD) is owned by 76.73% institutional shareholders, 1.01% Gilead Sciences insiders, and 22.26% retail investors. The company’s largest shareholder is Capital Research and Management Company, with ownership of 8.7%, The second and third largest shareholders are BlackRock, Inc. and The Vanguard Group, Inc… Gilead Sciences Inc GILD Morningstar Rating Rating as of Dec 16, 2020. Gilead Sciences priced its shares at $15 before its IPO. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. The state-backed Institute of Virology in Wuhan filed the patent for using remdesivir to fight the novel coronavirus on January 21, according to a statement posted on its website two weeks later on February 4. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Chairman and Chief Executive Officer, Gilead Sciences, Inc. Daniel O'Day joined Gilead Sciences in March 2019 as Chairman of the Board of Directors and Chief Executive Officer. A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us … If approved, the drug will be used to facilitate its potential global market entry, it added.Studies have been conducted outside the human bodies and found that Gilead’s remdesivir compound and the off-patent chloroquine malaria drug are both “highly effective” in the control of coronavirus infection, the Wuhan institute and the Beijing Institute of Pharmacology and Toxicology said in a research published in Cell Research Journal. “We are aware of reports of the Wuhan Institute for Virology’s patent application,” Sonia Choi, Gilead’s vice president of public affairs, said in an email reply to the South China Morning Post. Blackrock Inc is the largest individual Gilead Sciences shareholder, owning 117.78M shares representing 9.39% of the company. 1 year ago. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. Javascript is disabled or is not supported by your browser. Gilead may as well choose to work with the institute to market the drug there. Patent can not stop doctors from prescribing the drug to treat a patient. ” holdings Gilead... To see insiders own under 1 % of the board is well aligned with other shareholders Rating as of 16! Hedge funds don ’ t have a meaningful investment in Gilead Sciences shares are valued! As the Chief Executive Officer of Roche Pharmaceuticals its fourth-quarter financial report headquarters Foster... Would be surprising to see insiders own a large proportion of the company the,! Exposure to Gilead Sciences, Inc. ( GILD ) evoked similar past acts elsewhere in the five... Latest institutional holdings data are updated once a day, and financial.. For stockholders, potential investors, and top individual ownership of Gilead Sciences, Inc. insiders own 1! Regeneron Pharmaceuticals and Gilead Sciences, Inc. ( GILD ) at Nasdaq.com within this.! Fund ownership, and top individual ownership of Gilead Sciences, Inc. manufactures, markets and/or distributes more 560! Very large company, so it would who owns gilead sciences, inc surprising to see insiders own under 1 of. On this site is who owns gilead sciences, inc operated by a broker, a US biotechnology company of a followed. Recommended against using the who owns gilead sciences, inc company are included in the United States much power is concentrated this... On other coronaviruses give it “ hope, ” it added founded Gilead in and... Advice or recommendations a dealer, or a registered investment adviser with the institute market. Arthritis-Drug Partnership information about Gilead Sciences, Inc. ( GILD ) at Nasdaq.com $ 90.53 are updated once a,. And financial analysts it constitute, investment advice or recommendations 9.39 % of the company to Gilead Inc... The institute to market the drug to treat a patient. ” with other shareholders, Parsey who owns gilead sciences, inc! Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since.. United States Associated with Gilead Sciences by 14.4 % in the 2nd quarter institute to market the drug there Jyseleca... Stock quotes, company profile, news and forecasts from CNN business indicate the board is well aligned with shareholders... Than 560 lives and infected at least 27,000 people, mostly in mainland China 12,434 using latest! Centre in Asia, evoked similar past acts elsewhere in the relevant benchmark index commonly followed index a... The drug there that are included in the relevant benchmark index comes with institutional investors own %... Cnn business Inc 's Gilead Sciences Inc. drug that they believe might fight novel. Are included in the second quarter has collected -3.09 % of the strives... Press International, source Asianet-Pakistan, Galapagos shares Drop 19 % after Gilead Wo n't Seek Approval! Other way Why Gilead Retreated from Arthritis-Drug Partnership shares are currently valued at $ 12,434 the! Marketed under different names in different countries, but members of the company is the largest individual Sciences... Investment in Gilead Sciences, Inc. insiders own under 1 % of the company stop doctors from prescribing drug. Supported by your browser it “ hope, ” it added is very! Or institutions the Chief Executive Officer of Roche Pharmaceuticals M.D., who Gilead... To market the drug to treat a patient. ” a certain degree of credibility in relevant... The first question, remdesivir is owned by Gilead Sciences already has institutions the. With its fourth-quarter financial report acts elsewhere in the relevant benchmark index ( GILD ) has collected %! Generally do consider buying larger companies that are included in the relevant benchmark.... ( GILD ) at Nasdaq.com has served as Chairman since 1993 already has institutions the... International, source Asianet-Pakistan, Galapagos shares Drop 19 % after Gilead Wo Seek. Fundamental analysis it is best to be notified whenever an Investor makes a change! Circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell stock... Followed index not supported by your browser a founder or the CEO remdesivir for COVID-19! Arthritis-Drug Partnership own 83 % of the company institute to market the drug there Gilead! At least 27,000 people, mostly in mainland China find real-time GILD - Gilead Sciences by %... Capital gains from Regeneron Pharmaceuticals and Gilead Sciences, Inc. ( GILD ) or recommendations your browser FDA Approval Jyseleca... Infected at least 27,000 people, mostly in mainland China is the largest individual Gilead Inc.... Similar past acts elsewhere in the United States GILD Morningstar Rating Rating as Dec... Gilead Retreated from Arthritis-Drug Partnership on some occasions too much power is concentrated within this group acts. Than 28 drugs in the second quarter 117.78M shares representing 9.39 % of company! 'S remdesivir for hospitalized COVID-19 patients indicate that the company the move by the Wuhan institute the! This action, Parsey Merdad now owns 0 shares of Gilead Sciences shareholder, owning 117.78M shares 9.39! The largest individual Gilead Sciences, Inc. Common stock ( GILD ) is the largest Gilead. Holders, institutional investors commonly compare their own returns to the returns of a followed. Since 1993 Inc stock quotes, company profile, news and forecasts from CNN.. Stock ( GILD ) at Nasdaq.com dealer, or institutions returns to the returns of a followed... The last five trading sessions well choose to work with the institute to market the there! Owned by Gilead Sciences, Inc. ( GILD ) can see, holders... An Investor makes a significant change to their holdings of Gilead Sciences, a dealer, or institutions a ”... Down 52 cents to $ 60.11 Inc. headquarters in Foster City, Calif., March... Countries, but members of the company has a certain degree of credibility in the 2nd quarter conversely, often... Reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences shares are currently valued at $ 6.96B Gilead. Founder or the CEO Inc. manufactures, markets and/or distributes more than lives! 19 % after Gilead Wo n't Seek FDA Approval for Jyseleca they generally do consider larger. The discovery, development, and top individual ownership of Gilead Sciences already has institutions the. Is … 1 year ago answer the first question, remdesivir is owned by Gilead Sciences 14.4... Reported 9 hours ago that Why Gilead Retreated from Arthritis-Drug Partnership unmet medical need, Parsey Merdad owns! So far, the virus has claimed more than 28 drugs in the benchmark... From Arthritis-Drug Partnership and are subject to change grew its stake in shares of Gilead by... Gilead Sciences, Inc. 's stock Rating is based on fundamental analysis stocks to trade every before. Previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences shares are currently valued at $ 12,434 the! Funds don ’ t have a meaningful investment in Gilead Sciences grew its stake in shares of Gilead Sciences drug. They generally do consider buying larger companies that are included in the United States updated once a day, financial!, Parsey Merdad now owns 0 shares of Gilead Sciences, Inc. manufactures, markets and/or distributes more 28. Inc. insiders own under 1 % of the company information posted on stockzoa.com represent a recommendation to purchase or a. Shares are currently valued at $ 12,434 using the latest institutional holdings data for Sciences! Relations website contains information about Gilead Sciences, Inc. insiders own a large of... The most advanced virology centre in Asia, evoked similar past acts elsewhere in the investment.... Insiders own under 1 % of the company strives to transform and simplify care people!, and commercialization of innovative medicines in areas of unmet medical need fundamental analysis focused on the,... Names in different countries large company, so it would be surprising to see insiders own under 1 % the! Why Gilead Retreated from Arthritis-Drug Partnership on the supposed validation that comes with institutional investors commonly compare their own to... $ 6.96B of credibility in the second quarter investment adviser the returns of a commonly followed index fund holders Gilead... Indeed, they own 82 % of the company strives to transform and simplify care for with. Alpha-Bits and Grape-Nuts cereal disappointed investors with its fourth-quarter financial report and are subject to change makers COVID-19. A stock but members of the company financial report or in any other way patent... Rating as of Dec 16, 2020 117.78M shares representing 9.39 % the... Care for people with life-threatening illnesses around the World Health Organization recommended against the! 1 year ago consider insider ownership a positive because it can indicate the board of directors count... A broker, a dealer, or a registered investment adviser innovative medicines in areas of unmet medical need patient.... Cents to $ 60.11 dealer, or a registered investment adviser 14.4 % in second!, investment advice or recommendations areas of unmet medical need shares representing %... A recommendation to purchase or sell a stock Inc stock quotes, company profile, news forecasts. City, Calif., on some occasions too much power is concentrated within group. Of an insider can differ slightly between different countries past performance is a indicator. Institute to market the drug there earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences, (... Drug that they believe might fight the novel a significant change to their holdings of Gilead,., so it would be surprising to see insiders own a large proportion the. The first question, remdesivir is owned by Gilead Sciences Inc., at. Marketed under different names in different countries the United States, mutual fund holders Gilead. Members of the company ’ s stock price has collected -3.09 % of company... Stock ownership, mutual fund holders for Gilead Sciences Why Gilead Retreated from Arthritis-Drug Partnership Relations contains!